FSB Sees Some Progress in OTC Reform
Progress has been made in setting and implementing international standards for over-the-counter (OTC) derivatives market reforms in a number of jurisdictions, according to the latest progress report by the Financial Stability Board (FSB).
Published every six months, the FSB report reviews progress made by international standard-setting bodies, national and regional authorities, and market participants toward getting all standardized OTC contracts to be traded on exchanges or electronic trading platforms and cleared through central counterparties (CCPs), having OTC derivative contracts be reported to trade repositories, and making non-centrally cleared contracts be subject to higher capital requirements.
The jurisdictions with the largest markets in OTC derivatives—the EU, Japan and the US—are the most advanced in structuring their legislative and regulatory frameworks, the report says. They expect to have regulatory frameworks in place by the end of 2012 and practical implementation within their markets is well under way. Other jurisdictions are generally less advanced. One reason is that some jurisdictions have been waiting for the key elements of the regulatory frameworks in the EU, Japan and the US to be finalized before putting their own legislation in place. Others have sought greater certainty about the application of international principles and safeguards to cross-border financial market infrastructure.
Based on its findings, the FSB recommends that market participants expand the number and scope of OTC derivatives transactions that are standardized, centrally cleared, traded on organized platforms and reported to trade repositories.
In the next progress report, to be published before the November G20 Finance Ministers and Central Bank Governors meeting, the FSB intends to put additional focus on the readiness of infrastructures to provide central clearing, platform trading and reporting of OTC derivatives, the practical ability of industry to meet the requirements, and the remaining steps for industry to take.
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe
You are currently unable to print this content. Please contact info@waterstechnology.com to find out more.
You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@waterstechnology.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@waterstechnology.com
More on Regulation
Caveat creator: GenAI giants’ pledges won’t pre-empt copyright suits
Tech vendors offer indemnities on generative output, but end-users need to check the fine print, warn IP lawyers
Bank-led consortium takes aim at position reporting
Five banks, including Barclays, BNP Paribas, Goldman Sachs and HSBC, have joined forces to mitigate interpretation and implementation errors in position reporting disclosures.
Verafin launches genAI copilot for fincrime investigators
Features include document summarization and improved research tools.
Waters Wrap: Open source and storm clouds on the horizon
Regulators and politicians in America and Europe are increasingly concerned about AI—and, by extension, open-source development. Anthony says there are real reasons for concern.
DSB says industry is ready to meet UPI mandate ahead of deadline
The Unique Product Identifier will be required for certain OTC derivatives in the EU at the end of April, following US adoption in January.
‘Very careful thought’: T+1 will introduce costs, complexities for ETF traders
When the US moves to T+1 at the end of May 2024, firms trading ETFs will need to automate their workflows as much as possible to avoid "settlement misalignment" and additional costs.
Court case probes open-source licenses as movement stands at crossroads
The Software Freedom Conservancy’s lawsuit against TV-maker Vizio begins trial in California, raising questions about open-source licenses and the risks posed by adhering to them.
Waters Wavelength Podcast: Countdown to T+1
DTCC’s Val Wotton joins the podcast this week to discuss the impending move to T+1 in the US.
Most read
- IMD & IRD Awards 2024: All the winners
- Waters Wavelength Podcast: Bloomberg’s Tony McManus
- Most innovative market data project—Tradeweb